Follow-The-Filings

Security · featured owners

PRAX Praxis Precision Medicines I

COM NEW Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.0%
  • $2M
  • 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 0.0% (Polen Capital Management) · not free-float ownership

  1. Polen Capital Management reduce 0.02%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Polen Capital Management 2026 Q2 0.02% Reduce −27.8% 7,252 $2M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.45M $8.55M $0.00
Net income -$123.28M -$182.82M -$303.27M
Net margin * -5037.9% -2137.5% —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $84.88M $404.37M $610.91M
Total non-current assets * $3.07M $78.74M $327M
Total assets $87.95M $483.11M $937.91M
Total current liabilities $15.75M $37.55M $59.77M
Total non-current liabilities * $2.53M $110,000 $0.00
Total equity $64.47M $229.68M $878.14M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$111.14M -$131.76M -$249.07M
Cash from investing $38.95M -$248.49M -$311.15M
Cash from financing $91.87M $514.32M $702.17M
Net change in cash $19.68M $134.07M $141.96M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders